|
WO2005094263A2
|
|
Methods of determining the prognosis and treatment of subjects with colon cancer
|
|
WO2005076958A2
|
|
Methods of determining the prognosis and treatment of subjects with pin 1 associated disorders
|
|
US2006106077A1
|
|
Pin1-Modulating compounds and methods of use thereof
|
|
WO2004094601A2
|
|
Methods of treating pin1 associated disorders by covalent modification of active site residues
|
|
WO2004093803A2
|
|
Photochemotherapeutic compounds for use in treatment of pin1-associated states
|
|
WO2004046329A2
|
|
Levels of pin1 in normal and cancerous tissue
|
|
AU2003258982A8
|
|
Methods of inhibiting pin1-associated states using a fredericamycin a compound
|
|
US2004176277A1
|
|
Methods of treating Pin1 associated disorders
|
|
WO03074001A2
|
|
Methods for designing specific inhibitors for pin1 proline isomerase and pin1-related molecules
|
|
AU2003213673A1
|
|
Pin1-modulating compounds and methods of use thereof
|
|
AU2003217870A8
|
|
Pini-modulating compounds and methods of use thereof
|
|
AU2003216501A8
|
|
Methods of treating pin1 associated disorders
|
|
WO2004028535A1
|
|
Pin1-modulating compounds and methods of use thereof
|
|
US2005049267A1
|
|
Pin1-modulating compounds and methods of use thereof
|
|
AU2002255525B2
|
|
Pin1 as a marker for prostate cancer
|
|
CA2432981A1
|
|
Use of fredericamycin a and its derivatives in the treatment of pin1-associated states
|
